Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients
Condition:   Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Intervention:   Sponsors:   Royal Marsden NHS Foundation Trust;   Janssen, LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials